1. Home
  2. CBAN vs SPRY Comparison

CBAN vs SPRY Comparison

Compare CBAN & SPRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Colony Bankcorp Inc.

CBAN

Colony Bankcorp Inc.

N/A

Current Price

$21.39

Market Cap

423.6M

Sector

Finance

ML Signal

N/A

Logo ARS Pharmaceuticals Inc.

SPRY

ARS Pharmaceuticals Inc.

N/A

Current Price

$4.26

Market Cap

473.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CBAN
SPRY
Founded
1975
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
423.6M
473.4M
IPO Year
1995
2020

Fundamental Metrics

Financial Performance
Metric
CBAN
SPRY
Price
$21.39
$4.26
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$40.00
AVG Volume (30 Days)
101.5K
1.4M
Earning Date
04-22-2026
05-11-2026
Dividend Yield
2.44%
N/A
EPS Growth
16.91
N/A
EPS
0.90
N/A
Revenue
N/A
$84,278,000.00
Revenue This Year
$35.41
$87.40
Revenue Next Year
$4.84
$81.64
P/E Ratio
$23.84
N/A
Revenue Growth
N/A
N/A
52 Week Low
$15.80
$4.73
52 Week High
$22.46
$13.15

Technical Indicators

Market Signals
Indicator
CBAN
SPRY
Relative Strength Index (RSI) 49.12 28.41
Support Level $19.20 N/A
Resistance Level $21.78 $8.61
Average True Range (ATR) 0.38 0.30
MACD -0.00 -0.09
Stochastic Oscillator 60.82 2.70

Price Performance

Historical Comparison
CBAN
SPRY

About CBAN Colony Bankcorp Inc.

Colony Bankcorp Inc is a bank holding company. The bank provides a broad range of banking services to its retail and commercial customers. Its product line includes loans to small and medium-sized businesses, residential and commercial construction and land development loans, commercial real estate loans, agri-business and production loans, residential mortgage loans, consumer loans, and a variety of demand, savings, and time deposit products. The company's segments include the Banking Division, Retail Mortgage Division and small business specialty lending divisions. It generates maximum revenue from the Banking Division.

About SPRY ARS Pharmaceuticals Inc.

ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the commercialization and development of neffy (currently identified in the European Union (EU) and United Kingdom (U.K.) by the trade name EURneffy and in China) for needle-free intranasal delivery of epinephrine for emergency treatment of Type I allergic reactions, including anaphylaxis. Neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows Neffy to safely provide intranasal delivery of epinephrine at a low dose within the exposures of approved injectable products across a range of dosing conditions.

Share on Social Networks: